Skip Navigation


European Heart Journal Advance Access originally published online on July 11, 2007
European Heart Journal 2007 28(16):1917-1919; doi:10.1093/eurheartj/ehm265
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/16/1917    most recent
ehm265v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Spencer, F. A.
Right arrow Articles by Steg, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spencer, F. A.
Right arrow Articles by Steg, P. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Major bleeding after PCI. Where is our crystal ball?

Frederick A. Spencer1 and Philippe Gabriel Steg2,*

1 Department of Medicine, McMaster University Medical Center, Hamilton, Canada
2 Department of Cardiology, Hôpital Bichat-Claude Bernard, Université Paris 7–Denis Diderot, Paris, France

* Corresponding author. Tel: +33 1 40 25 86 68. E-mail address: gabriel.steg@bch.aphp.fr

This editorial refers to ‘Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach’ by E. Nikolsky et al., on page 1936

The first 10% of the full text of this article appears below.

Over the last three decades, there have been remarkable advances in percutaneous coronary intervention (PCI). Utilization of coronary stents and combination antiplatelet/antithrombotic therapy have led to significant improvements in revascularization success rates as well as marked reductions in thrombotic complications. Patients considering elective procedures are now routinely quoted a < 1% risk of incurring a myocardial infarction or of requiring urgent revascularization. These advances have led to exponential increases in the utilization of PCI in patients with both stable and unstable coronary artery disease (CAD) over the last decade—it is now estimated that > 800 000 PCI procedures are performed annually in Europe.1 In addition, PCI is being performed in increasingly complex patients, including the elderly and those with multiple co-morbidities, who are at higher risk for incurring procedural complications.

However, with increased utilization of PCI, increased . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach
Eugenia Nikolsky, Roxana Mehran, George Dangas, Martin Fahy, Yingbo Na, Stuart J. Pocock, A. Michael Lincoff, and Gregg W. Stone
EHJ 2007 28: 1936-1945. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 ChestHome page
S. Manzano-Fernandez, F. J. Pastor, F. Marin, F. Cambronero, C. Caro, D. A. Pascual-Figal, I. P. Garrido, E. Pinar, M. Valdes, and G. Y. H. Lip
Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting
Chest, September 1, 2008; 134(3): 559 - 567.
[Abstract] [Full Text] [PDF]